Cargando…

Metabolic derangement in patients with vitiligo: a cross-sectional study

Vitiligo is a pigmentary disorder resulting from progressive destruction of melanocytes in the skin. There is a growing body of evidence about higher risk of metabolic syndrome and dyslipidemia in some dermatoses including vitiligo. We aimed to evaluate lipid profile, leptin and C reactive protein (...

Descripción completa

Detalles Bibliográficos
Autores principales: Aryanian, Zeinab, Shirzadian, Azar, Farzaneh, Sepideh, Goodarzi, Azadeh, Azizpour, Arghavan, Hatami, Parvaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016231/
https://www.ncbi.nlm.nih.gov/pubmed/35169000
http://dx.doi.org/10.1136/jim-2021-002062
_version_ 1784688486081626112
author Aryanian, Zeinab
Shirzadian, Azar
Farzaneh, Sepideh
Goodarzi, Azadeh
Azizpour, Arghavan
Hatami, Parvaneh
author_facet Aryanian, Zeinab
Shirzadian, Azar
Farzaneh, Sepideh
Goodarzi, Azadeh
Azizpour, Arghavan
Hatami, Parvaneh
author_sort Aryanian, Zeinab
collection PubMed
description Vitiligo is a pigmentary disorder resulting from progressive destruction of melanocytes in the skin. There is a growing body of evidence about higher risk of metabolic syndrome and dyslipidemia in some dermatoses including vitiligo. We aimed to evaluate lipid profile, leptin and C reactive protein (CRP) status among Iranian patients with vitiligo, compared with healthy controls and perused the relationship between abnormal values of these parameters with disease duration and physical characteristics of patients. 40 patients with vitiligo and 40 age-matched and sex-matched healthy controls were enrolled in the study. Data on weight, height, lipid profile, leptin and CRP values were recorded and compared. The mean values for nearly all study parameters (except for high-density lipoprotein) were significantly higher in patients with vitiligo, compared with healthy controls, irrespective of age and sex. We could not find any correlation between vitiligo and study parameters, regarding disease severity and extension of lesions; but in patients who have been suffering from vitiligo for more than 5 years, systolic blood pressure, diastolic blood pressure and CRP values were noted to be significantly higher (p<0.001, p=0.003 and p=0.03, respectively). In conclusion, screening of patients with vitiligo in regard to their lipid profile as well as blood pressure should be considered, especially in patients with longer disease duration or those who have other cardiovascular risk factors to prevent morbidity and mortality as a result of developing cardiovascular events.
format Online
Article
Text
id pubmed-9016231
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-90162312022-05-04 Metabolic derangement in patients with vitiligo: a cross-sectional study Aryanian, Zeinab Shirzadian, Azar Farzaneh, Sepideh Goodarzi, Azadeh Azizpour, Arghavan Hatami, Parvaneh J Investig Med Original Research Vitiligo is a pigmentary disorder resulting from progressive destruction of melanocytes in the skin. There is a growing body of evidence about higher risk of metabolic syndrome and dyslipidemia in some dermatoses including vitiligo. We aimed to evaluate lipid profile, leptin and C reactive protein (CRP) status among Iranian patients with vitiligo, compared with healthy controls and perused the relationship between abnormal values of these parameters with disease duration and physical characteristics of patients. 40 patients with vitiligo and 40 age-matched and sex-matched healthy controls were enrolled in the study. Data on weight, height, lipid profile, leptin and CRP values were recorded and compared. The mean values for nearly all study parameters (except for high-density lipoprotein) were significantly higher in patients with vitiligo, compared with healthy controls, irrespective of age and sex. We could not find any correlation between vitiligo and study parameters, regarding disease severity and extension of lesions; but in patients who have been suffering from vitiligo for more than 5 years, systolic blood pressure, diastolic blood pressure and CRP values were noted to be significantly higher (p<0.001, p=0.003 and p=0.03, respectively). In conclusion, screening of patients with vitiligo in regard to their lipid profile as well as blood pressure should be considered, especially in patients with longer disease duration or those who have other cardiovascular risk factors to prevent morbidity and mortality as a result of developing cardiovascular events. BMJ Publishing Group 2022-04 2022-02-15 /pmc/articles/PMC9016231/ /pubmed/35169000 http://dx.doi.org/10.1136/jim-2021-002062 Text en © American Federation for Medical Research 2022. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Aryanian, Zeinab
Shirzadian, Azar
Farzaneh, Sepideh
Goodarzi, Azadeh
Azizpour, Arghavan
Hatami, Parvaneh
Metabolic derangement in patients with vitiligo: a cross-sectional study
title Metabolic derangement in patients with vitiligo: a cross-sectional study
title_full Metabolic derangement in patients with vitiligo: a cross-sectional study
title_fullStr Metabolic derangement in patients with vitiligo: a cross-sectional study
title_full_unstemmed Metabolic derangement in patients with vitiligo: a cross-sectional study
title_short Metabolic derangement in patients with vitiligo: a cross-sectional study
title_sort metabolic derangement in patients with vitiligo: a cross-sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016231/
https://www.ncbi.nlm.nih.gov/pubmed/35169000
http://dx.doi.org/10.1136/jim-2021-002062
work_keys_str_mv AT aryanianzeinab metabolicderangementinpatientswithvitiligoacrosssectionalstudy
AT shirzadianazar metabolicderangementinpatientswithvitiligoacrosssectionalstudy
AT farzanehsepideh metabolicderangementinpatientswithvitiligoacrosssectionalstudy
AT goodarziazadeh metabolicderangementinpatientswithvitiligoacrosssectionalstudy
AT azizpourarghavan metabolicderangementinpatientswithvitiligoacrosssectionalstudy
AT hatamiparvaneh metabolicderangementinpatientswithvitiligoacrosssectionalstudy